ArticleHaematologica2012

AMD3100 disrupts the cross-talk between chronic lymphocytic leukemia cells and a mesenchymal stromal or nurse-like cell-based microenvironment: pre-clinical evidence for its association with chronic lymphocytic leukemia treatments.

Basile Stamatopoulos et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.